Maria D'Souza1, Lærke Smedegaard2, Christian Madelaire2, Dorte Nielsen3, Christian Torp-Pedersen4, Gunnar Gislason5, Morten Schou2, Emil Fosbøl6. 1. Department of Cardiology, Copenhagen University Hospital Herlev-Gentofte, Hellerup, Denmark. Electronic address: maria.dsouza.diederichsen@regionh.dk. 2. Department of Cardiology, Copenhagen University Hospital Herlev-Gentofte, Hellerup, Denmark. 3. Department of Clinical Oncology, Copenhagen University Hospital Herlev-Gentofte, Herlev, Denmark. 4. Department of Cardiology, Copenhagen University Hospital Herlev-Gentofte, Hellerup, Denmark; Department of Health, Science and Technology, Aalborg University, and Department of Epidemiology/Biostatistics and Cardiology, Aalborg University Hospital, Aalborg, Denmark. 5. Department of Cardiology, Copenhagen University Hospital Herlev-Gentofte, Hellerup, Denmark; The Danish Heart Foundation, Copenhagen, Denmark; The National Institute of Public Health, University of Southern Denmark, Odense M, Denmark. 6. Department of Cardiology, University Hospital of Copenhagen, Rigshospitalet, Denmark.
Abstract
BACKGROUND: Patients with breast cancer may have an increased incidence of atrial fibrillation (AF) because of the systemic inflammation induced by the cancer and side effects of treatments. OBJECTIVE: The purpose of this study was to estimate the long-term incidence of AF in patients with breast cancer compared with the background population. METHODS: We identified patients diagnosed with breast cancer from 1998 to 2015 by using nationwide registries. Female patients with breast cancer were matched (1:3) by age and sex with the background population. The long-term incidence of AF was estimated by cumulative incidence curves and multivariable Cox regression models. RESULTS: We matched 74,155 patients with breast cancer with 222,465 patients from the background population. Breast cancer was associated with incident AF and the association differed between age groups (interaction analysis, P < .0001) and follow-up time periods. In patients younger than 60 years breast cancer was associated with increased incidence of AF during the first 6 months (hazard ratio [HR] 2.10; 95% confidence interval [CI] 1.25-3.44) and from 6 months to 3 years (HR 1.80; 95% CI 1.38-2.35). In patients older than 60 years, breast cancer was not associated with increased incidence of AF during the first 6 months (HR 1.13; 95% CI 0.95-1.34) and was associated with increased incidence of AF from 6 months to 3 years (HR 1.14; 95% CI 1.05-1.25). CONCLUSION: The long-term incidence of AF was increased in patients with breast cancer and short-term incidence was increased in patients younger than 60 years and similar in patients older than 60 years compared with the background population.
BACKGROUND:Patients with breast cancer may have an increased incidence of atrial fibrillation (AF) because of the systemic inflammation induced by the cancer and side effects of treatments. OBJECTIVE: The purpose of this study was to estimate the long-term incidence of AF in patients with breast cancer compared with the background population. METHODS: We identified patients diagnosed with breast cancer from 1998 to 2015 by using nationwide registries. Female patients with breast cancer were matched (1:3) by age and sex with the background population. The long-term incidence of AF was estimated by cumulative incidence curves and multivariable Cox regression models. RESULTS: We matched 74,155 patients with breast cancer with 222,465 patients from the background population. Breast cancer was associated with incident AF and the association differed between age groups (interaction analysis, P < .0001) and follow-up time periods. In patients younger than 60 years breast cancer was associated with increased incidence of AF during the first 6 months (hazard ratio [HR] 2.10; 95% confidence interval [CI] 1.25-3.44) and from 6 months to 3 years (HR 1.80; 95% CI 1.38-2.35). In patients older than 60 years, breast cancer was not associated with increased incidence of AF during the first 6 months (HR 1.13; 95% CI 0.95-1.34) and was associated with increased incidence of AF from 6 months to 3 years (HR 1.14; 95% CI 1.05-1.25). CONCLUSION: The long-term incidence of AF was increased in patients with breast cancer and short-term incidence was increased in patients younger than 60 years and similar in patients older than 60 years compared with the background population.
Authors: Avirup Guha; Michael G Fradley; Susan F Dent; Neal L Weintraub; Maryam B Lustberg; Alvaro Alonso; Daniel Addison Journal: Eur Heart J Date: 2022-01-31 Impact factor: 35.855
Authors: Husam Abdel-Qadir; Paaladinesh Thavendiranathan; Kinwah Fung; Eitan Amir; Peter C Austin; Geoffrey S Anderson; Douglas S Lee Journal: JAMA Netw Open Date: 2019-09-04
Authors: Nachiket Apte; Parinita Dherange; Usman Mustafa; Lina Ya'qoub; Desiree Dawson; Kathleen Higginbotham; Marjan Boerma; Daniel P Morin; Dipti Gupta; Jerry McLarty; Richard Mansour; Paari Dominic Journal: Front Cardiovasc Med Date: 2021-01-22
Authors: Manish Kumar; Nerea Lopetegui-Lia; Christina Al Malouf; Mansour Almnajam; Patrick P Coll; Agnes S Kim Journal: J Geriatr Cardiol Date: 2022-01-28 Impact factor: 3.327